PMC:7299399 / 1457-1640
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T78571 | 175-182 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T8 | 53-58 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T9 | 114-125 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T10 | 175-182 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 0-183 | Sentence | denotes | In this case, nanomaterials could be used to deliver drugs to the pulmonary system to inhibit interaction between angiotensin-converting enzyme 2 (ACE2) receptors and viral S protein. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
17 | 114-145 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
18 | 147-151 | Gene | denotes | ACE2 | Gene:59272 |
19 | 173-174 | Gene | denotes | S | Gene:43740568 |